Matthew L. Sherman, EVP & Chief Medical Officer: Deciphera Pharmaceuticals DCPH Sell · Filed 24/02/20

Trade details

Type: Insider sale
Amount: $40,846.3
Shares · price: 2,615 sh · $15.62 a share
Held after: 108,739 sh
Stock: Deciphera Pharmaceuticals DCPH
Person: Matthew L. ShermanEVP & Chief Medical Officer
Trade date: 24/02/16
Filed: 24/02/20
Days to filing: 4 days

Sold 2.3% of holdings

Share of holding sold: 2.3%

Deciphera Pharmaceuticals trades, last 26 weeks

What else happened in Deciphera Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/01/17~24/03/17

Matthew L. Sherman's recent trades

Matthew L. ShermanEVP & Chief Medical Officer
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$35.2K
2,435 sh
$35.2K
Filed 24/01/18
Traded 24/01/16
Matthew L. ShermanEVP & Chief Medical Officer
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$42.9K
2,792 sh
$42.9K
Filed 23/12/14
Traded 23/12/13
Matthew L. ShermanEVP & Chief Medical Officer
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$28.4K
2,360 sh
$28.4K
Filed 23/10/31
Traded 23/10/30
Matthew L. ShermanEVP & Chief Medical Officer
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$37.3K
2,942 sh
$37.3K
Filed 23/10/04
Traded 23/10/02
Matthew L. ShermanEVP & Chief Medical Officer
SellDeciphera Pharmaceuticals
Sell
Deciphera Pharmaceuticals
DCPH
$23.8K
1,655 sh
$23.8K
Filed 23/06/21
Traded 23/06/16